Infectious Disease Immunoassay Market Size Forecasted to Reach

Source Domain: www.openpr.com

According to Precedence Research, the global infectious disease immunoassay market size was estimated at USD 2.88 billion in 2025 and is forecasted to reach around USD 8.87 billion by 2035, growing at a robust CAGR of 11.90%.
Immunoassays have become indispensable tools across hospitals, diagnostic laboratories, and public health systems, enabling accurate detection of viral, bacterial, and parasitic infections. With growing global health challenges and a shift toward decentralized healthcare, the market is poised for sustained expansion.

Where Data Meets Strategic Clarity 📥 View Sample Pages of the Complete Report 👉 https://www.precedenceresearch.com/sample/8237

Market Size and Forecasts

🔹 Market size in 2025: USD 2.88 Billion
🔹 Market size in 2026: USD 3.22 Billion
🔹 Market size by 2035: USD 8.87 Billion
🔹 CAGR: 11.90% (2026-2035)
🔹 Forecast period: 2026-2035
🔹 Base year: 2025

How is Artificial Intelligence Transforming Infectious Disease Immunoassays?

Artificial intelligence (AI) is playing a transformative role in enhancing the accuracy and efficiency of immunoassay diagnostics. AI-powered algorithms are being integrated into diagnostic platforms to enable faster data interpretation, reduce human error, and support clinical decision-making. This is especially crucial in high-throughput laboratories handling large volumes of patient samples.

Moreover, AI is enabling predictive diagnostics by analyzing patterns in infectious disease outbreaks and patient data. This allows healthcare providers to anticipate disease spread and implement early intervention strategies. The convergence of AI with immunoassay platforms is expected to revolutionize disease detection and surveillance in the coming years.

🔗 What’s Fueling the Next Wave of Growth? 👉 https://www.precedenceresearch.com/infectious-disease-immunoassay-market

Infectious Disease Immunoassay Market Key Growth Drivers

🔸 Rising Burden of Infectious…

Source